ORMP icon

Oramed Pharmaceuticals
ORMP

Overview Fund Trends Analyst Outlook Journalist POV

51 hedge funds and large institutions have $15.4M invested in Oramed Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

9% less funds holding

Funds holding: 56 → 51 (-5)

38% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 13

Holders
51
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$43K
Puts
$26K
Net Calls
Net Calls Change

Top Buyers

1
+$962K
2
+$872K
3
+$481K
4
VF
Virtu Financial
New York
+$68K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$60.4K

Top Sellers

1
-$1.22M
2
-$640K
3
-$245K
4
Squarepoint
Squarepoint
New York
-$82.2K
5
Citadel Advisors
Citadel Advisors
Florida
-$72.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$292
52
–
53
–
54
–
55
–
56
–
57
–
58
–
59
–
60
–
61
–
62
–
63
–
64
–
1 2
3